Top Contract Research Organizations (CROs) In APAC
We’re thrilled to present the Top Contract Research Organizations (CROs) In APAC, a prestigious honor recognizing the industry’s game-changers. These exceptional businesses were nominated by our subscribers based on impeccable reputation and the trust these companies have garnered from our valued subscribers. After an intense selection process—led by C-level executives, industry pioneers and our expert editorial team—only the best have made the cut. These companies have been selected as recipients of the award, celebrating their leadership and innovation.
Top Contract Research Organizations (CROs) In APAC
Equilab International is the first and largest pharmacokinetics CRO in Indonesia, providing end-to-end services for drug development. From bioanalytical testing and clinical trial management to regulatory support and data analysis, it ... read full profile
CMIC Group is Japan’s pioneering and largest contract research organisation, offering fully integrated, end-to-end services across the pharmaceutical lifecycle. Its capabilities span preclinical research, clinical development, GMP-compliant manufacturing, regulatory support and commercial launch, enabling efficient drug development from concept to market.
Emerald Clinical is a global CRO rooted in the Asia-Pacific that leverages 20+ years of experience and 40+ international locations to run Phase I–IV trials. It combines deep therapeutic-area strength in renal, oncology, and cardiometabolic research with strong recruitment networks, data integrity, regulatory agility and patient-centric execution worldwide.
Novotech blends Asia-Pacific trial speed with global CRO rigor, giving emerging biotechs a single engine for Phase I–IV studies, biometrics, site networks and regulatory strategy. Its hybrid model turns complex, multi-country trials into fast, data-strong pathways that move therapies to patients sooner.
CRO News





